MAGELLAN LONGEVITY
HomeTopical Pain Relief › Voltaren Arthritis Pain Gel (Diclofenac 1%)

Voltaren Arthritis Pain Gel (Diclofenac 1%)

Written and medically reviewed by , physiatrist · Last reviewed · How we grade
In one paragraph

Voltaren Arthritis Pain Gel (Diclofenac 1%), graded Strong-evidence on Magellan — in the Cochrane analysis about 60% of users achieved at least halved pain, with a number-needed-to-treat of roughly 10 over 6 to 12 weeks. The benefit is real but limited: effect sizes are modest, there is little evidence for painful conditions other than osteoarthritis, and the most common side effects are mild application-site skin reactions.

Source: Cochrane Database Syst Rev 2016, PMID 27103611 ↗ · Topical Pain Relief · How Magellan grades evidence · Study write-up · evidence confidence: high

Topical Pain Relief17 PubMed citations
$25.59 typical listed price — check the live price on Amazon
View Voltaren Arthritis Pain Gel (Diclofenac 1%) on Amazon ↗   Open in the Magellan store →

What it is

Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclo-oxygenase (COX) enzymes, reducing synthesis of the prostaglandins that drive inflammation and pain. Applied to the skin as a 1% gel (the active ingredient in Voltaren Arthritis Pain), it penetrates locally into underlying joints and soft tissue while producing much lower systemic drug levels than oral diclofenac. Topical diclofenac is used for temporary relief of arthritis pain in joints such as the hands, wrists, elbows, knees, ankles and feet, and in 2020 the 1% gel was switched from prescription to over-the-counter status in the United States.

Its role in longevity

Randomized trials and meta-analyses, including Cochrane reviews, indicate that topical diclofenac provides modest but statistically significant pain relief and functional improvement in hand and knee osteoarthritis — in the Cochrane analysis about 60% of users achieved at least halved pain, with a number-needed-to-treat of roughly 10 over 6 to 12 weeks — with efficacy broadly comparable to oral NSAIDs but fewer gastrointestinal and systemic adverse effects because only a small fraction of the drug is absorbed. The benefit is real but limited: effect sizes are modest, there is little evidence for painful conditions other than osteoarthritis, and the most common side effects are mild application-site skin reactions; a safety review focused on older adults found topical NSAIDs preferable to oral agents on systemic-safety grounds. Major osteoarthritis guidelines nonetheless recommend topical NSAIDs as an early, first-line option, particularly for older adults and people at increased risk from oral NSAIDs. This evidence describes the diclofenac compound and the topical NSAID class generally, not this specific commercial product.

The research

Peer-reviewed studies on the active compound — citations link to PubMed.

“In studies lasting 6 to 12 weeks, topical diclofenac and topical ketoprofen were significantly more effective than carrier for reducing pain; about 60% of participants had much reduced pain.”
Cochrane Database Syst Rev 2016 · PMID 27103611
“Topical diclofenac formulations (gel, solution, patch) significantly improve pain and function in knee osteoarthritis compared to placebo. All formulations were well-tolerated.”
BMC Musculoskelet Disord 2025 · PMID 40065343
“Of all topical NSAIDs, diclofenac patches were most effective for OA pain (SMD=-0.81, 95% CI -1.12 to -0.52) and piroxicam was most effective for functional improvement (SMD=-1.04, 95% CI -1.60 to -0.48) compared with placebo.”
Br J Sports Med 2018 · PMID 29436380
“In comparison to the vehicle control, the mean differences for WOMAC pain, stiffness, and physical function subscales, as well as pain on walking, were all statistically significant in favor of topical diclofenac solution.”
Biomed Res Int 2020 · PMID 33299860
“At week 12, the DSG group had significant decreases versus the vehicle group in mean WOMAC pain (P = 0.01), mean WOMAC physical function (P = 0.001), and mean global rating of disease (P < 0.001).”
Semin Arthritis Rheum 2009 · PMID 19932833
“Diclofenac sodium gel decreased pain intensity scores by 42%-45%, total AUSCAN scores by 35%-40%, and global rating of disease by 36%-40%.”
J Rheumatol 2009 · PMID 19648310

Research describes the active mechanism and is not a claim about this specific product.

Educational information, not medical advice. This product is not intended to diagnose, treat, cure, or prevent any disease. Talk to your physician before starting any supplement or device, especially if pregnant, nursing, or taking medication.

More in Topical Pain Relief

Capzasin-HP Capsaicin 0.1% Pain Relief Cream

Randomized trials and meta-analyses show that topical capsaicin produces modest…

Aspercreme 4% Lidocaine Pain Relief Cream

The best-supported use of topical lidocaine is localized neuropathic pain, especially…

Biofreeze Menthol Pain Relief Gel

Menthol is used for the temporary relief of minor muscle and joint pain, including…

Salonpas Pain Relieving Patch (Methyl Salicylate + Menthol)

Randomized trials of methyl-salicylate/menthol patches and menthol-based topical…

See all Topical Pain Relief →

FAQ

Does Voltaren Arthritis Pain Gel (Diclofenac 1%) have scientific evidence?

Yes — its active compound is linked to 17 peer-reviewed studies, summarized and cited above.

Where can I buy Voltaren Arthritis Pain Gel (Diclofenac 1%)?

You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.

Is Voltaren Arthritis Pain Gel (Diclofenac 1%) safe?

Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.